News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Peck Ronald
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 1,324 shares
@ $24.3871, valued at
$32.3k
Exercised 4,010 restricted stock units
@ $0 |
|
02/24/2023 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 19,125 shares
@ $0 Granted 57,450 options to buy
@ $34.37, valued at
$2M
|
|
08/16/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2022 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 11,371 shares
@ $80.35, valued at
$913.7k
Sold 8,629 shares
@ $80.96, valued at
$698.6k
Exercised 14,375 options to buy
@ $47.38, valued at
$681.1k
Exercised 5,625 options to buy
@ $26.58, valued at
$149.5k
|
|
07/02/2021 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 20,000 shares
@ $76.69, valued at
$1.5M
Exercised 20,000 options to buy
@ $47.38, valued at
$947.6k
|
|
03/02/2021 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 68,000 options to buy
@ $78.3, valued at
$5.3M
|
|
02/18/2021 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 20,000 shares
@ $77.3496, valued at
$1.5M
Exercised 20,000 options to buy
@ $26.58, valued at
$531.6k
|
|
08/18/2020 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 1,256 shares
@ $27.46, valued at
$34.5k
Exercised 4,010 restricted stock units
@ $0 |
|
03/02/2020 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 75,000 options to buy
@ $47.38, valued at
$3.6M
|
|
|
|